Status:
UNKNOWN
The Effect of Slow Breathing Exercise Applied to Patients on Pulse, Blood Pressure and Quality of Life
Lead Sponsor:
Saglik Bilimleri Universitesi
Collaborating Sponsors:
The Scientific and Technological Research Council of Turkey
Conditions:
Slow Breathing
Acute Myocardial Infarction
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study was designed as a randomized controlled experimental type in order to determine the effect of slow breathing exercise applied after the procedure on heart rate, blood pressure and quality o...
Detailed Description
Cardiovascular Diseases (CVD) is still the leading cause of death in the world and in our country, despite significant advances in its diagnosis and treatment. Acute Coronary Syndromes (ACS), which ar...
Eligibility Criteria
Inclusion
- Young adult patients between the ages of 18-65,
- Patients who have not received fibrinolytic therapy before or simultaneously with Percutaneous Coronary Intervention (PCI) procedure,
- Patients who have passed 24 hours after the PCI procedure,
- Patients with a pulse \> 60/min (whether or not beta blockers are used after PCI),
- Patients without rhythm problems,
- Patients with hypertension (systolic blood pressure 140-179 mmHg, diastolic blood pressure 90-109 mmHg), (whether or not they use antihypertensive and beta blocker drugs),
- Patients without a diagnosis of mental or psychiatric disease,
- Patients who have the materials to watch the breathing exercise video,
- Patients who can receive reminder messages and make video calls (with devices such as a smartphone, computer, tablet, etc.),
- Patients with a portable blood pressure monitor suitable for pulse and blood pressure measurement during home monitoring (the necessary equipment will be provided within the scope of the TUBITAK project),
- Patients without hearing or visual impairment,
- Patients who can read and write
- Patients who can communicate,
- Patients without language problems,
- Patients who volunteer and indicate this verbally and in writing
Exclusion
- Patients with elective/appointed appointments for whom PCI is planned in advance,
- Patients whose PCI procedure failed,
- Patients who underwent only thrombus aspiration and balloon angioplasty during the PCI procedure,
- Patients who have previously undergone PCI and at least one year has not passed since,
- Patients who do not comply with planned interventions,
- Patients who do not volunteer to participate in the study,
- Patients with physical limitations and respiratory distress who cannot do breathing exercises,
- Patients with rhythm problems,
- Patients with diseases that can increase heart rate (anemia, hyperthyroidism, hyperthermia, infection),
- Patients who are morbidly obese (Body Mass Index \> 40 kg/m2),
- Patients with hearing impairment,
- Patients with mental disabilities or perception problems,
- Patients who have previously received breathing therapy training will not be included in the study.
Key Trial Info
Start Date :
October 23 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06098222
Start Date
October 23 2023
End Date
October 1 2024
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Provincial Directorate of Health Koşuyolu High Specialization Education and Research Hospital
Istanbul, Turkey (Türkiye), 34852